文献速递腹部泌尿生殖MR

磁共振肾实质T2作为常染色体显性多囊肾病的新型影像生物标志物

Magnetic Resonance Kidney Parenchyma-T2 as a Novel Imaging Biomarker for Autosomal Dominant Polycystic Kidney Disease.
PubMed 文献 · Invest Radiol · 2020-01-01

研究纳入139例常染色体显性多囊肾病患者和10名健康对照,在1.5T磁共振上采集梯度回波-自旋回波T2 mapping序列,评估肾实质T2与囊肿分数、htTKV及血清和肽素的相关性。结果显示肾实质T2计算速度比htTKV和全肾T2快6至10倍,与囊肿分数相关性(r=0.77)强于htTKV(r=0.48),且能最清晰区分不同囊肿分数组。

要点

  • 肾实质T2与囊肿分数相关性(r=0.77)强于htTKV(r=0.48),可辅助评估疾病严重程度。
  • 肾实质T2计算耗时0.78±0.14分钟,显著短于htTKV的4.78±1.17分钟和全肾T2的7.59±1.57分钟。
  • 肾实质T2与血清和肽素相关性最强(r=0.37),在肾功能保留患者中上述表现更明显。

关键影像表现/征象

  • 在T2图上测量双肾平均T2弛豫时间(全肾T2)及残余肾实质T2弛豫时间(肾实质T2)。
  • 肾实质T2与囊肿分数呈强相关(r=0.77,P<0.001),全肾T2与囊肿分数的相关性相似(r=0.76,P<0.001)。
  • 肾实质T2与血清和肽素相关性最强(r=0.37,P<0.001)。

诊断标准与关键数值

  • 肾实质T2与囊肿分数的相关系数r=0.77(P<0.001),全肾T2为r=0.76(P<0.001),htTKV为r=0.48(P<0.001)。
  • 肾实质T2计算耗时0.78±0.14分钟,htTKV为4.78±1.17分钟(P<0.001),全肾T2为7.59±1.57分钟(P<0.001)。
  • 肾实质T2与血清和肽素的相关系数r=0.37(P<0.001)。

临床应用与阅片要点

  • 肾实质T2可在T2图上快速测量,耗时约0.78分钟,便于日常临床工作流程中应用。
  • 肾实质T2与囊肿分数的相关性优于htTKV,可用于辅助患者咨询和治疗方案选择。
  • 在肾功能保留的患者中,肾实质T2与疾病严重程度的相关性更为明显。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Autosomal dominant polycystic kidney disease (ADPKD) is a chronic progressive disorder with a significant disease burden leading to end-stage renal disease in more than 75% of the affected individuals. Although prediction of disease progression is highly important, all currently available biomarkers-including height-adjusted total kidney volume (htTKV)-have important drawbacks in the everyday clinical setting. Thus, the purpose of this study was to evaluate T2 mapping as a source of easily obtainable and accurate biomarkers, which are needed for improved patient counseling and selection of targeted treatment options.

MATERIALS AND METHODS: A total of 139 ADPKD patients from The German ADPKD Tolvaptan Treatment Registry and 10 healthy controls underwent magnetic resonance imaging on a clinical 1.5-T system including acquisition of a Gradient-Echo-Spin-Echo T2 mapping sequence. The ADPKD patients were divided into 3 groups according to kidney cyst fraction (0%-35%, 36%-70%, >70%) as a surrogate marker for disease severity. The htTKV was calculated based on standard T2-weighted imaging. Mean T2 relaxation times of both kidneys (kidney-T2) as well as T2 relaxation times of the residual kidney parenchyma (parenchyma-T2) were measured on the T2 maps.

RESULTS: Calculation of parenchyma-T2 was 6- to 10-fold faster than determination of htTKV and kidney-T2 (0.78 ± 0.14 vs 4.78 ± 1.17 minutes, P < 0.001; 0.78 ± 0.14 vs 7.59 ± 1.57 minutes, P < 0.001). Parenchyma-T2 showed a similarly strong correlation to cyst fraction (r = 0.77, P < 0.001) as kidney-T2 (r = 0.76, P < 0.001), the strongest correlation to the serum-derived biomarker copeptin (r = 0.37, P < 0.001), and allowed for the most distinct separation of patient groups divided according to cyst fraction. In contrast, htTKV showed an only moderate correlation to cyst fraction (r = 0.48, P < 0.001). These observations were even more evident when considering only patients with preserved kidney function.

CONCLUSIONS: The rapidly assessable parenchyma-T2 shows a strong association with disease severity early in disease and is superior to htTKV when it comes to correlation with renal cyst fraction.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Siedek F, Grundmann F, Weiss K, et al. Magnetic Resonance Kidney Parenchyma-T2 as a Novel Imaging Biomarker for Autosomal Dominant Polycystic Kidney Disease. Invest Radiol. 2020. PMID: 31876626. doi:10.1097/RLI.0000000000000633

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。